Picture of Alpine Immune Sciences logo

ALPN — Alpine Immune Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Vertex to acquire Alpine Immune Sciences for $4.9 bln

April 10 (Reuters) - Vertex Pharmaceuticals  VRTX.O 
will acquire Alpine Immune Sciences  ALPN.O  for $65 per share,
or about $4.9 billion in cash, the companies said on Wednesday.

 (Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi
Majumdar)
 ((Christy.Santhosh@thomsonreuters.com))

Recent news on Alpine Immune Sciences

See all news